1. Home
  2. VERA vs DEI Comparison

VERA vs DEI Comparison

Compare VERA & DEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$36.74

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Logo Douglas Emmett Inc.

DEI

Douglas Emmett Inc.

HOLD

Current Price

$12.05

Market Cap

1.8B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERA
DEI
Founded
2016
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
1.8B
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
VERA
DEI
Price
$36.74
$12.05
Analyst Decision
Strong Buy
Hold
Analyst Count
10
8
Target Price
$81.30
$12.94
AVG Volume (30 Days)
954.9K
2.4M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
7.06%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,003,982,000.00
Revenue This Year
N/A
$1.70
Revenue Next Year
$472.48
$2.35
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.77
52 Week Low
$18.76
$9.04
52 Week High
$56.05
$16.94

Technical Indicators

Market Signals
Indicator
VERA
DEI
Relative Strength Index (RSI) 43.71 69.16
Support Level $34.04 $10.85
Resistance Level $42.77 $12.40
Average True Range (ATR) 1.86 0.36
MACD 0.01 0.12
Stochastic Oscillator 41.27 77.21

Price Performance

Historical Comparison
VERA
DEI

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About DEI Douglas Emmett Inc.

Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments: the office segment and multifamily segment, of which Office segment derives maximum revenue.

Share on Social Networks: